InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
68,726.23
(
0.29%
)

Replies to post #474 on Eagle Pharmaceuticals, inc. (EGRX)

Replies to #474 on Eagle Pharmaceuticals, inc. (EGRX)

DewDiligence

07/14/16 2:52 PM

#475 RE: Bickema #474

Kangio does not infringe any of MDCO's remaining Angiomax patents, so EGRX will almost certainly launch Kangio as soon as the FDA approves it.